The use of intranasal ketamine before puncturing a vein in children

Ketamine intranasal used as sedative for punch venosa in pediatric patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-9ztf3b

Enrollment

Unknown

Registered

2016-05-05

Start date

2015-11-16

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease, acute respiratory failure, poisoning by drugs and medications, acute pain, allergies, digestive disorders

Interventions

This study consists of two arms: placebo and intervention. Patients in the intervention group receiving ketamine drug dose 4 mg / kg once, and those in the placebo group received saline at a dose 4 mg

Drug

E03.250

D26.660

Eligibility

Age

3 Months to 12 Years

Inclusion criteria

Inclusion criteria: Children hospitalized in the Pediatric Inpatient Units, with the presence of legal guardian; aged 3 months to 12 years; requiring venipuncture independent research.

Exclusion criteria

Exclusion criteria: Severe neurological sequelae; Patients who need immediate venipuncture at risk; Presence of active nosebleeds; Patients using antipsicotrópicos; Children who have experienced clinical change with ketamine

Design outcomes

Primary

Measure	Time frame
Decreased venipuncture time in sedated patients with a variation of 3 and a difference of 3 minutes compared to patients not sedated, checked by timing the venipuncture time	—

Secondary

Measure	Time frame
Easier implementation of venipuncture performed by nurses using a questionnaire as a tool	—

Countries

Brazil

Contacts

Public ContactSabrina Pinheiro

Hospital de Clínicas de Porto Alegre

sassa0812@hotmail.com+555181822674

Outcome results

None listed

Source: REBEC (via WHO ICTRP)